Syros Pharmaceuticals Inc (SYRS)
0.3212
-0.04
(-10.75%)
USD |
NASDAQ |
Nov 14, 10:23
Syros Pharmaceuticals Price: 0.3212 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 0.3975 | 0.4096 | 0.35 | 0.3599 | 37.68M |
| Nov 12, 2024 | 3.38 | 3.38 | 2.72 | 2.73 | 10.38M |
| Nov 11, 2024 | 2.63 | 3.40 | 2.63 | 3.23 | 1.017M |
| Nov 08, 2024 | 2.57 | 2.68 | 2.550 | 2.61 | 349423.0 |
| Nov 07, 2024 | 2.45 | 2.62 | 2.437 | 2.56 | 225699.0 |
| Nov 06, 2024 | 2.59 | 2.69 | 2.41 | 2.45 | 329069.0 |
| Nov 05, 2024 | 2.42 | 2.59 | 2.42 | 2.53 | 133240.0 |
| Nov 04, 2024 | 2.28 | 2.530 | 2.221 | 2.43 | 399023.0 |
| Nov 01, 2024 | 2.07 | 2.326 | 2.06 | 2.265 | 523538.0 |
| Oct 31, 2024 | 2.53 | 2.620 | 2.44 | 2.52 | 291621.0 |
| Oct 30, 2024 | 2.46 | 2.584 | 2.31 | 2.51 | 557487.0 |
| Oct 29, 2024 | 2.09 | 2.77 | 2.03 | 2.53 | 1.359M |
| Oct 28, 2024 | 2.00 | 2.170 | 2.00 | 2.11 | 198178.0 |
| Oct 25, 2024 | 2.07 | 2.154 | 1.98 | 2.00 | 260484.0 |
| Oct 24, 2024 | 2.26 | 2.36 | 2.02 | 2.07 | 741946.0 |
| Oct 23, 2024 | 2.47 | 2.553 | 2.20 | 2.25 | 477122.0 |
| Oct 22, 2024 | 2.23 | 2.692 | 2.111 | 2.47 | 1.267M |
| Oct 21, 2024 | 1.93 | 2.24 | 1.89 | 2.24 | 1.724M |
| Oct 18, 2024 | 1.95 | 1.979 | 1.939 | 1.96 | 123670.0 |
| Oct 17, 2024 | 1.93 | 1.97 | 1.87 | 1.95 | 140528.0 |
| Oct 16, 2024 | 1.96 | 1.986 | 1.82 | 1.91 | 284323.0 |
| Oct 15, 2024 | 1.99 | 2.08 | 1.96 | 1.99 | 204270.0 |
| Oct 14, 2024 | 1.95 | 1.98 | 1.93 | 1.97 | 89767.00 |
| Oct 11, 2024 | 1.94 | 1.97 | 1.91 | 1.93 | 159710.0 |
| Oct 10, 2024 | 1.94 | 1.98 | 1.90 | 1.95 | 101204.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.3212
Minimum
Nov 14 2024
149.50
Maximum
Jan 19 2021
35.65
Average
9.70
Median
Jun 16 2022
Price Benchmarks
| Baxter International Inc | 32.26 |
| AbbVie Inc | 169.28 |
| Elanco Animal Health Inc | 14.05 |
| Opus Genetics Inc | 1.085 |
| Entrada Therapeutics Inc | 19.50 |
Price Related Metrics
| PS Ratio | 1.189 |
| Earnings Yield | -955.8% |
| Market Cap | 8.619M |